{
  "id": 4876033,
  "title": "Elevance Health (ELV) Soars as Investors Gain Confidence in Profitability",
  "url": "https://urgent.news/2026/09/01/elevance-health-elv-soars-as-investors-gain-confidence-in",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-01T14:19:33.000Z",
  "source": {
    "name": "Yahoo Finance",
    "slug": "yahoo-finance",
    "url": "https://finance.yahoo.com/markets/stocks/articles/elevance-health-elv-soars-investors-141933883.html"
  },
  "original_language": "en",
  "account": "Elevance Health, Inc. (NYSE:ELV), formerly known as Anthem, experienced a surge in stock price during Q2 2026, as highlighted in First Eagle Global Fund's Q2 2026 investor letter. The company's shares closed at $392.54 per share on August 31, 2026, reflecting a 21.78% increase over the past year. Despite concerns about fiscal constraints and limited policy flexibility, strong demand for financial assets, led by AI infrastructure developments, contributed to a positive market environment. The fund's performance was primarily driven by emerging markets and developed Europe, with information technology and financials leading among equity sectors. Elevance Health, Inc. (NYSE:ELV) saw a 3.85% gain over the past month, with its shares trading within a 52-week range of $274.84 to $436.24. The fund underperformed relative to the MSCI World Index during the quarter, but Elevance Health, Inc. (NYSE:ELV) still emerged as a notable contributor.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}